In the current global market landscape, small-cap stocks have been navigating mixed signals from economic indicators, with the S&P 600 reflecting a nuanced sentiment amid fluctuating interest rates and inflation concerns. As investors assess these dynamics, identifying stocks that demonstrate potential value through insider activity can be particularly appealing in this environment.
Top 10 Undervalued Small Caps With Insider Buying Globally
| Name | PE | PS | Discount to Fair Value | Value Rating |
|---|---|---|---|---|
| Q Technology (Group) | 3.5x | 0.2x | 42.81% | ★★★★★☆ |
| China Aircraft Leasing Group Holdings | 7.0x | 0.9x | 38.24% | ★★★★★☆ |
| Timbercreek Financial | 17.4x | 10.1x | 36.31% | ★★★★☆☆ |
| Diversified Royalty | 25.5x | 10.1x | 46.12% | ★★★★☆☆ |
| Nexus Industrial REIT | 9.9x | 3.0x | 10.33% | ★★★★☆☆ |
| Pizza Pizza Royalty | 11.4x | 8.7x | 42.99% | ★★★★☆☆ |
| Saniona | 7.2x | 3.1x | 31.80% | ★★★★☆☆ |
| Sagicor Financial | 6.6x | 0.5x | -70.02% | ★★★★☆☆ |
| AB Dynamics | NA | 1.8x | 22.32% | ★★★☆☆☆ |
| Travis Perkins | NA | 0.3x | -213.47% | ★★★☆☆☆ |
Underneath we present a selection of stocks filtered out by our screen.
Cromwell Property Group (ASX:CMW)
Simply Wall St Value Rating: ★★★★★☆
Overview: Cromwell Property Group is a real estate investment and management company with operations focused on co-investments, an investment portfolio, and asset management, boasting a market capitalization of A$2.32 billion.
Operations: The company generates revenue primarily from its Investment Portfolio, which contributes A$185.20 million, and Investment and Asset Management services, adding A$27.30 million. The gross profit margin has shown fluctuations over time, reaching 85.68% in the most recent period.
PE: 6.3x
Cromwell Property Group, a player in the property sector, recently reported a turnaround with net income of A$135.8 million for the fiscal year ending June 2026, contrasting with last year's loss. Despite earnings growth concerns, insider confidence is evident as Jonathan Callaghan increased their stake by over 36% through purchasing nearly 1.05 million shares valued at A$395,527. The company also announced an unfranked dividend of A$0.00775 per share for Q3 2026, reflecting potential shareholder value amidst its small cap nature and external funding reliance.
- Get an in-depth perspective on Cromwell Property Group's performance by reading our valuation report here.
Evaluate Cromwell Property Group's historical performance by accessing our past performance report.
Growthpoint Properties Australia (ASX:GOZ)
Simply Wall St Value Rating: ★★★★☆☆
Overview: Growthpoint Properties Australia is a real estate investment trust focusing on office and industrial properties, with a market capitalization of approximately A$3.55 billion.
Operations: Growthpoint Properties Australia's revenue primarily comes from its Office and Industrial segments, with the Office segment contributing a significant portion. The company has experienced fluctuations in its net income margin, which reached as high as 2.48% but also saw negative values more recently. Operating expenses have shown an upward trend over time, impacting overall profitability.
PE: 15.4x
Growthpoint Properties Australia, a smaller company in the property sector, reported a significant turnaround with net income of A$90.8 million for the year ending June 30, 2026, compared to a net loss previously. Despite flat revenue growth at A$331.2 million and interest payments not being well covered by earnings, insider confidence is evident as they increased their holdings over the past year. The company anticipates steady dividend distributions for FY27 at 18.4 cents per share, signaling stability amidst its external borrowing reliance.
Edding Genor Group Holdings (SEHK:6998)
Simply Wall St Value Rating: ★★★☆☆☆
Overview: Edding Genor Group Holdings is a company involved in the manufacturing and distribution sector, with operations contributing significantly to its market presence.
Operations: The company generates revenue primarily through its manufacturing and distribution segment, with recent figures showing CN¥2.22 billion. Its cost structure includes a notable portion allocated to operating expenses, such as sales and marketing, R&D, and general administrative costs. The gross profit margin has shown a trend around 68%, indicating efficiency in managing production costs relative to revenue.
PE: 13.2x
Edding Genor Group Holdings, a smaller company, has faced challenges with a 3.6% revenue decline over the past year and a shift from net profit to net loss in the first half of 2026. Despite this, insider confidence is evident as their CEO purchased 2.4 million shares for CNY 4.1 million between March and September 2026, indicating belief in future potential. The company focuses on innovative drugs like Vascepa and Rujianing, expecting significant growth despite recent setbacks due to national drug procurement policies impacting sales. Their strategic emphasis on research and development aims to enhance their market position in high-growth therapeutic areas such as breast cancer treatment and chronic diseases, supported by global collaborations like the GB261 transaction bringing USD 48 million cash inflow in July 2026.
- Navigate through the intricacies of Edding Genor Group Holdings with our comprehensive valuation report here.
Understand Edding Genor Group Holdings' track record by examining our Past report.
Taking Advantage
- Explore the 122 names from our Undervalued Global Small Caps With Insider Buying screener here.
- Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
- Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Curious About Other Options?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com